Patent · US Active

Process or making N-hydroxy-3[4-[[[2-(2methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefor

US8536346B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Murat Acemoglu · Basel, CH
Joginder S. Bajwa · Elmwood Park, US
David John Parker · West Milford, US
Joel Slade · Flanders, US

Key dates

Filing date	Sep 23, 2011
Grant date	Sep 17, 2013
Priority date	—
Expiry date	Sep 23, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefore are prepared by new synthetic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.